IDEAS home Printed from https://ideas.repec.org/a/spr/pharme/v30y2012i12d10.2165_11596490-000000000-00000.html
   My bibliography  Save this article

Cost Effectiveness of Therapeutic Interventions in Ankylosing Spondylitis

Author

Listed:
  • Cécile Gaujoux-Viala

    (Université Pierre et Marie Curie (UPMC) Paris VI, GRC-UMPC 08 (EEMOIS)
    AP-HP, Pitié Salpêtrière Hospital
    Lorraine University, Paris Descartes University)

  • Bruno Fautrel

    (Université Pierre et Marie Curie (UPMC) Paris VI, GRC-UMPC 08 (EEMOIS)
    AP-HP, Pitié Salpêtrière Hospital
    Hôpital Pitié-Salpêtrière)

Abstract

Objectives This report reviews the cost effectiveness of different therapeutic interventions used in the treatment of ankylosing spondylitis (AS). Methods We performed a systematic search of the databases MEDLINE via PubMed, EMBASE and the Cochrane Library and used hand-searching to identify articles on cost effectiveness of therapies for adult patients with AS published up to November 2010. Results Of 135 articles, 13 studies were analysed. Two articles were on physical therapies, one article was on NSAIDs and ten articles were on tumour necrosis factor (TNF) inhibitors (infliximab = 6, etanercept = 2, infliximab and etanercept = 1 and adalimumab = 1). Of the latter, no article directly compared TNF inhibitors. Articles showed substantial heterogeneity in methodological approaches and thus results, which prevented us from any extensive comparison, data pooling or meta-analysis. The incremental cost-effectiveness ratio (ICER) for spa-exercise treatment was €7465 (95% CI 3294, 14 686) per QALY. The ICERs for infliximab, etanercept and adalimumab were €5307–237 010, €29 815–123 761 and €7344-33 303 per QALY, respectively. Conclusions Modelling treatment strategies in chronic relapsing diseases such as AS presents specific challenges, as reflected in the variation in the cost-effectiveness results reported. Although quite variable, the cost-effectiveness ratios for AS therapies remain within an acceptable range.

Suggested Citation

  • Cécile Gaujoux-Viala & Bruno Fautrel, 2012. "Cost Effectiveness of Therapeutic Interventions in Ankylosing Spondylitis," PharmacoEconomics, Springer, vol. 30(12), pages 1145-1156, December.
    • Handle: RePEc:spr:pharme:v:30:y:2012:i:12:d:10.2165_11596490-000000000-00000
    DOI: 10.2165/11596490-000000000-00000
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.2165/11596490-000000000-00000
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    File URL: https://libkey.io/10.2165/11596490-000000000-00000?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:pharme:v:30:y:2012:i:12:d:10.2165_11596490-000000000-00000. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.